Skip to main content
Selvita S.A. logo

Selvita S.A. — Investor Relations & Filings

Ticker · SLV ISIN · PLSLVCR00029 LEI · 25940057WQ9YP5MOQF28 WAR Professional, scientific and technical activities
Open in API
Filings indexed 1,179 across all filing types
Latest filing 2020-03-26 Audit Report / Informat…
Country PL Poland
Listing WAR SLV

About Selvita S.A.

https://selvita.com/

Selvita S.A. is a preclinical contract research organization (CRO) providing integrated services for the pharmaceutical and biotechnology sectors. The company offers comprehensive solutions across the drug discovery and development continuum, from target validation to preclinical candidate nomination. Core drug discovery capabilities include medicinal chemistry, pharmacology, DMPK, and protein sciences, supporting a wide range of modalities such as small molecules, antibodies, and protein degraders. For drug development, Selvita provides analytical support for small and large molecules, formulation, microbiology services, and manufacturing for clinical trials. The company operates under GMP and GLP quality standards, offering flexible engagement models that range from standalone studies to fully integrated programs.

Recent filings

Filing Released Lang Actions
Sprawozdanie firmy audytorskiej z badania rocznego sprawozdania finansowego za rok 2019
Audit Report / Information Classification · 99% confidence The document is titled "SPRAWOZDANIE NIEZALEŻNEGO BIEGŁEGO REWIDENTA Z BADANIA" (Independent Auditor's Report on the Audit) and specifically mentions the audit of the annual financial statements ("Sprawozdanie z badania rocznego sprawozdania finansowego") for Selvita S.A. as of December 31, 2019. It contains the auditor's opinion, the basis for the opinion, and details Key Audit Matters (Kluczowe sprawy badania), which are standard components of an auditor's report. Although the period covered (March 22, 2019, to December 31, 2019) is unusual, the document's core function is to provide an audit opinion on the financial statements. This aligns directly with the definition of an Audit Report / Information (AR), which covers standalone audit reports, distinct from the full Annual Report (10-K) which contains the financial statements themselves plus management discussion and analysis, etc. Given the content is the auditor's report, AR is the most appropriate classification. FY 2019
2020-03-26 Polish
Zawarcie kolejnych znaczących zleceń - Content (PL)
Regulatory Filings Classification · 95% confidence The document text, written in Polish, announces that a subsidiary of the Issuer (Selvita S.A.) received two new orders from a UK-based pharmaceutical company. It specifies the estimated value of these new orders (EUR 995,505) and the cumulative estimated value of orders for the year (EUR 1,243,684). The management board deems these orders significant for the Issuer's development. This type of announcement, detailing new business contracts or significant commercial agreements that impact the company's outlook or financial standing, most closely aligns with a general regulatory announcement or a significant business update. Since there is no specific category for 'New Contract Award' and it is not a standard financial report (10-K, IR, ER), it falls best under the general 'Regulatory Filings' (RNS) category, which serves as a fallback for miscellaneous regulatory announcements not covered elsewhere. Given the short length and the nature of the announcement (a material event disclosure), RNS is the most appropriate fit.
2020-03-13 Polish
Otrzymanie kolejnych zleceń w ramach umowy znaczącej - Content (PL)
Regulatory Filings Classification · 85% confidence The document is a short announcement (902 characters) from the Management Board ('Zarząd') of Selvita S.A. It details receiving two new orders ('Zlecenia') from a US-based client under an existing framework agreement. It specifies the value of these new orders ($971,350 USD) and updates the total value of the contract to be executed in 2020. The management board deems this contract significant ('uznaje tę Umową jako znaczącą') and notes the expansion of cooperation is important for future development. This content relates to business contracts, significant operational developments, and management commentary, but it is not a formal financial report (10-K, IR), an earnings release (ER), or a specific capital/financing event (CAP). Since it is a management disclosure regarding a significant business event/contract, it best fits the Management Reports (MDA) category, which covers management's explanation of business trends and outlook, or potentially Regulatory Filings (RNS) if it were a general disclosure. Given the specific nature of reporting on significant contracts and management's assessment of their importance, MDA is the most appropriate fit among the specific categories, although it is brief. However, because it is a direct disclosure of a significant business event/contract award by the management board, and not a detailed explanation of financial results, it leans towards a general regulatory disclosure. Given the options, and the fact that it's a specific business update rather than a general regulatory filing fallback, MDA is plausible. Re-evaluating the definitions: MDA is 'Management's detailed explanation of financial results, business trends, and outlook.' This is a specific contract update. Since it's a material business event disclosure, and not a standard financial report, it could fall under RNS (Regulatory Filings) as a general announcement, or potentially be related to future revenue recognition which might be covered elsewhere. Given the lack of a perfect fit for a specific contract award announcement, and its nature as a formal disclosure by the management board about a significant business development, RNS (Regulatory Filings) serves as the most appropriate general category for material, non-standard disclosures not covered by other specific codes.
2020-02-19 Polish
Rejestracja obniżenia kapitału zakładowego i umorzenie akcji własnych Spółki w związku z podziałem Selvita - Content (PL)
Share Issue/Capital Change Classification · 98% confidence The document text, written in Polish, details a formal corporate action: the reduction of the share capital ('obniżenia kapitału zakładowego') by canceling 125,000 own shares ('umorzenia 125.000 akcji własnych Spółki'). It explicitly states the new capital amount, the number of shares, and updates the company's Statute ('Statutu Spółki'). This action directly relates to changes in the company's capital structure following a corporate division. This aligns precisely with the definition of 'Capital/Financing Update' (CAP), which covers fundraising, financing activities, or capital structure changes. It is not an earnings release, an annual report, or a simple announcement of a report's publication.
2020-02-19 Polish
Otrzymanie kolejnych zleceń w ramach umowy znaczącej - Content (PL)
Regulatory Filings Classification · 95% confidence The document is a short announcement (894 characters) from the Management Board ('Zarząd') of Selvita S.A. It details receiving two new orders ('zlecenia') from a UK biotech company under an existing framework agreement. The announcement specifies the value of these new orders and the cumulative value of the agreement for 2020, concluding that the agreement is 'significant' ('znaczącą') and important for the company's development. This content relates to business contracts, significant transactions, and updates on operational scope, which aligns best with a general regulatory announcement or a specific business update. Since it is not a formal financial report (10-K, IR), an earnings release (ER), or a specific insider trade (DIRS), it fits best as a general Regulatory Filing (RNS) or potentially a Capital/Financing Update (CAP) if the contract value was deemed a major financing event, but RNS is the most appropriate general category for significant, non-standard operational news releases in Polish regulatory contexts when a more specific code isn't available. Given the nature of announcing a significant contract award, RNS is the most suitable fallback.
2020-02-13 Polish
Terminy przekazywania raportów okresowych w 2020 roku - Content (PL)
Report Publication Announcement Classification · 98% confidence The document text, written in Polish, explicitly states that the Management Board ('Zarząd') of Selvita S.A. is announcing the publication dates ('terminy publikacji raportów okresowych') for its periodic reports (annual, Q1, H1, Q3) for the year 2020, citing specific Polish financial regulations ('Rozporządzenie Ministra Finansów'). This is a formal announcement about when future reports will be released, rather than the reports themselves. According to Rule 2 (The 'MENU VS MEAL' Rule), a document announcing the publication of reports fits the definition of a Report Publication Announcement (RPA). The document length (1513 chars) is short, supporting this classification.
2020-01-23 Polish

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.